Novel Target Identified that Could Improve Safety of Therapy for Pancreatic Cancer
CAR T cell therapy is an immunotherapy that has shown great promise for the treatment of some blood cancers; however,…
New Standard for Borderline Resectable Pancreatic Cancer
New results suggest that the reference regimen should be neoadjuvant therapy with modified FOLFIRINOX (oxaliplatin 85 mg/m2, irinotecan 180 mg/m2,…
New Computational Tool Reliably Differentiates Between Cancer and Normal Cells From Single-Cell RNA-Sequencing Data
The new tool, dubbed CopyKAT (copy number karyotyping of aneuploid tumors), allows researchers to more easily examine the complex data…
What Will You Do With Your Dash?
Step Counts Correlated With QoL With SM-88 in Metastatic Pancreatic Cancer
All patients who enrolled on the trial and received treatment with SM-88 were given wearable devices to passively capture biometric…
No Time to Wait: UK Pancreatic Cancer Patients Struggle with Treatment and Diagnostic Delays
Ohio State Basic Scientist Researches Role of Key Proteins in Pancreatic Cancer
To date, no biomarker has been identified that is specific enough to detect pancreatic cancer at an early stage and…
Finding More Targets for Pancreatic Cancer Treatment
New Study to Shed Light on Microbiome’s Relationship to Pancreatic Cancer
The Consortium includes 11 sites across the country that are focusing on several large cohort studies. One of these studies…